Macimm,
nejsem psychiatr. A taky vim, ze v CR byvala situace takova, ze nikdo nechtel nic predepisovat. Ja mam s PND zkusenost osobni (synovi je ted 9 let), ovsem bydlim v zahranici. Vim, ze v te dobe v CR byly nazory dosti odlisne. Posledni dobou jsem narazila na nekolik zen, ktere kojily a braly AD, takze si myslim, ze se situace obraci.
Jinak jsem pozdeji pracovala jako dobrovolnik v oblasti Londyna, ktera patri mezi 20% nejdeprivovanejsich casti UK. Spolupracovala jsem na "vyrobe" dokumentu o doporucenych postupech pri lecbe poporodni deprese, takovy rozbor dostupnych studii. Takze neco o tom vim.
Od te doby pak vysla jeste jedna velice zajimava studie, ktera sledovala spojeni mezi mistem porodu, vedenim porodu a postnatalni depresi. To me velice potesilo, protoze mi prijde logicke, ze podelany porod muze vest az k te poporodni depresi.

Tady mas doporuceni anglickeho NHS ke kojeni a antidepresivum:

Depression - antenatal and postnatal - Management
Which antidepressant should I prescribe for a woman who is breastfeeding?

Ideally, premature or low birthweight infants should not be exposed to antidepressant drugs via breast milk. However, the decision whether to treat with an antidepressant will depend on the woman"s circumstances — seek specialist advice.
If the woman has been treated with an antidepressant during pregnancy, or has had a good response to a particular antidepressant in the past, consider continuing or prescribing this antidepressant, after careful consideration of the potential risks to the infant.
All tricyclic antidepressants (TCAs), except doxepin, can safely be given to a women who is breastfeeding, provided the infant is healthy and his or her progress is monitored.
Imipramine and nortriptyline are the preferred TCAs for the treatment of depression in breastfeeding women.
The selective serotonin reuptake inhibitors (SSRIs) paroxetine and sertraline can safely be given to a woman who is breastfeeding, provided the infant is healthy and his or her progress is monitored.
Citalopram and fluoxetine are less preferred, but could be considered if the woman has been successfully treated with one of these drugs during pregnancy.
The use of other antidepressants, such as monoamine oxidase inhibitors (MAOIs), serotonin and noradrenaline reuptake inhibitors (venlafaxine and duloxetine), and the newer antidepressants (mirtazapine and reboxetine) is not recommended first-line in breastfeeding women.
The use of St John"s wort is not recommended for the management of depression when breastfeeding.


A tady v pripade zajmu ten dokument:
http://www.ness.bbk.ac.uk/support/local-evaluation-findings/documents/1326.pdf